228 related articles for article (PubMed ID: 32377719)
1. Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer.
Li Z; Xuan Z; Chen J; Song W; Zhang S; Jin C; Zhou M; Zheng S; Song P
Int J Oncol; 2020 Jul; 57(1):161-170. PubMed ID: 32377719
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells.
Tolba MF; Esmat A; Al-Abd AM; Azab SS; Khalifa AE; Mosli HA; Abdel-Rahman SZ; Abdel-Naim AB
IUBMB Life; 2013 Aug; 65(8):716-29. PubMed ID: 23847086
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
[No Abstract] [Full Text] [Related]
4. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
[TBL] [Abstract][Full Text] [Related]
5. Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.
Onori P; DeMorrow S; Gaudio E; Franchitto A; Mancinelli R; Venter J; Kopriva S; Ueno Y; Alvaro D; Savage J; Alpini G; Francis H
Int J Cancer; 2009 Aug; 125(3):565-76. PubMed ID: 19358267
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells.
Watabe M; Hishikawa K; Takayanagi A; Shimizu N; Nakaki T
J Biol Chem; 2004 Feb; 279(7):6017-26. PubMed ID: 14625298
[TBL] [Abstract][Full Text] [Related]
7. Caffeic acid phenethyl ester inhibits the progression of ovarian cancer by regulating NF-?B signaling.
Liu GL; Han NZ; Liu SS
Biomed Pharmacother; 2018 Mar; 99():825-831. PubMed ID: 29710481
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells.
Lin HP; Jiang SS; Chuu CP
PLoS One; 2012; 7(2):e31286. PubMed ID: 22347457
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation.
Orban Z; Mitsiades N; Burke TR; Tsokos M; Chrousos GP
Neuroimmunomodulation; 2000; 7(2):99-105. PubMed ID: 10686520
[TBL] [Abstract][Full Text] [Related]
10. Ethanol extract of propolis and its constituent caffeic acid phenethyl ester inhibit breast cancer cells proliferation in inflammatory microenvironment by inhibiting TLR4 signal pathway and inducing apoptosis and autophagy.
Chang H; Wang Y; Yin X; Liu X; Xuan H
BMC Complement Altern Med; 2017 Sep; 17(1):471. PubMed ID: 28950845
[TBL] [Abstract][Full Text] [Related]
11. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks.
Chuu CP; Lin HP; Ciaccio MF; Kokontis JM; Hause RJ; Hiipakka RA; Liao S; Jones RB
Cancer Prev Res (Phila); 2012 May; 5(5):788-97. PubMed ID: 22562408
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of NF-kappaB inhibitors Bay 11-7085 and caffeic acid phenethyl ester to Ramos and other human B-lymphoma cell lines.
Berger N; Ben Bassat H; Klein BY; Laskov R
Exp Hematol; 2007 Oct; 35(10):1495-509. PubMed ID: 17889719
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death.
Jia Y; Jiang S; Chen C; Lu G; Xie Y; Sun X; Huang L
Mol Med Rep; 2019 Jun; 19(6):4863-4871. PubMed ID: 31059064
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signaling.
Kuo YY; Lin HP; Huo C; Su LC; Yang J; Hsiao PH; Chiang HC; Chung CJ; Wang HD; Chang JY; Chen YW; Chuu CP
Int J Mol Sci; 2013 Apr; 14(5):8801-17. PubMed ID: 23615471
[TBL] [Abstract][Full Text] [Related]
15. Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
Kang M; Lee KH; Lee HS; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2017; 12(9):e0184644. PubMed ID: 28910332
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition.
Lee Y; Shin DH; Kim JH; Hong S; Choi D; Kim YJ; Kwak MK; Jung Y
Eur J Pharmacol; 2010 Sep; 643(1):21-8. PubMed ID: 20599928
[TBL] [Abstract][Full Text] [Related]
17. Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters.
Qiu F; Chen J; Cao J; Diao F; Huang P
Oncol Rep; 2020 Sep; 44(3):1158-1168. PubMed ID: 32705228
[TBL] [Abstract][Full Text] [Related]
18. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
Ali S; Banerjee S; Schaffert JM; El-Rayes BF; Philip PA; Sarkar FH
J Cell Biochem; 2010 May; 110(1):171-81. PubMed ID: 20213764
[TBL] [Abstract][Full Text] [Related]
19. Anti-colon cancer effect of caffeic acid p-nitro-phenethyl ester in vitro and in vivo and detection of its metabolites.
Tang H; Yao X; Yao C; Zhao X; Zuo H; Li Z
Sci Rep; 2017 Aug; 7(1):7599. PubMed ID: 28790461
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
